NCT05218096 2025-01-09Study of ALXN2050 in Adult Participants With Generalized Myasthenia GravisAlexion Pharmaceuticals, Inc.Phase 2 Terminated70 enrolled 14 charts
NCT03178201 2021-07-16TGR1202 in Relapsed and Refractory Follicular LymphomaColumbia UniversityPhase 2 Terminated5 enrolled 5 charts